目次

Table of Contents

List of Tables

List of Figures
Introduction
Global Markets Direct Report Coverage
Herpes Labialis (Oral Herpes) - Overview
Herpes Labialis (Oral Herpes) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Herpes Labialis (Oral Herpes) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Herpes Labialis (Oral Herpes) - Companies Involved in Therapeutics Development
AiCuris Anti-infective Cures AG
Astellas Pharma Inc
Brandenburg Antiinfektiva GmbH
Dobecure SL
Heidelberg Immunotherapeutics Gmbh
Jupiter Wellness Inc
NanoViricides Inc
Rational Vaccines Inc
Shulov Innovative Science Ltd
Vironova Medical AB
Herpes Labialis (Oral Herpes) - Drug Profiles
amenamevir - Drug Profile
Product Description
Mechanism Of Action
Aspidasept - Drug Profile
Product Description
Mechanism Of Action
B-220 - Drug Profile
Product Description
Mechanism Of Action
Cold Sores - Drug Profile
Product Description
Mechanism Of Action
ethamsylate - Drug Profile
Product Description
Mechanism Of Action
HDIT-101 - Drug Profile
Product Description
Mechanism Of Action
JW-100 - Drug Profile
Product Description
Mechanism Of Action
JW-400 - Drug Profile
Product Description
Mechanism Of Action
NVHHV-101 - Drug Profile
Product Description
Mechanism Of Action
pritelivir - Drug Profile
Product Description
Mechanism Of Action
RVX-101HSV1 - Drug Profile
Product Description
Mechanism Of Action
ZEP-3 - Drug Profile
Product Description
Mechanism Of Action
ZEP-4 - Drug Profile
Product Description
Mechanism Of Action
Herpes Labialis (Oral Herpes) - Dormant Projects
Herpes Labialis (Oral Herpes) - Discontinued Products
Herpes Labialis (Oral Herpes) - Product Development Milestones
Featured News & Press Releases
Nov 17, 2020: Jupiter Wellness' JW-100 enters clinical trial for the treatment of Herpes
Aug 23, 2017: AiCuris Announces Final Patient Treated in Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes
Dec 01, 2016: AiCuris Announces Start of LipP 1: First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes
Nov 05, 2010: AiCuris To Present Preclinical And Phase I Data Of Anti-HSV Drug AIC316 At Antivirals Congress
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Herpes Labialis (Oral Herpes), 2022
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Herpes Labialis (Oral Herpes) - Pipeline by AiCuris Anti-infective Cures AG, 2022
Herpes Labialis (Oral Herpes) - Pipeline by Astellas Pharma Inc, 2022
Herpes Labialis (Oral Herpes) - Pipeline by Brandenburg Antiinfektiva GmbH, 2022
Herpes Labialis (Oral Herpes) - Pipeline by Dobecure SL, 2022
Herpes Labialis (Oral Herpes) - Pipeline by Heidelberg Immunotherapeutics Gmbh, 2022
Herpes Labialis (Oral Herpes) - Pipeline by Jupiter Wellness Inc, 2022
Herpes Labialis (Oral Herpes) - Pipeline by NanoViricides Inc, 2022
Herpes Labialis (Oral Herpes) - Pipeline by Rational Vaccines Inc, 2022
Herpes Labialis (Oral Herpes) - Pipeline by Shulov Innovative Science Ltd, 2022
Herpes Labialis (Oral Herpes) - Pipeline by Vironova Medical AB, 2022
Herpes Labialis (Oral Herpes) - Dormant Projects, 2022
Herpes Labialis (Oral Herpes) - Discontinued Products, 2022

List of Figures
Number of Products under Development for Herpes Labialis (Oral Herpes), 2022
Number of Products under Development by Companies, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022